Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical-trial record is displayed, including study design, eligibility criteria, interventions, outcomes, results-related dates, and supporting documents, in place of the access-error page.
    Difference
    58%
    Check dated 2026-11-08T14:58:21.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-11-01T16:13:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A general NIH notice about website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T15:11:50.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T15:30:51.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:53:20.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details and navigation for NCT03851588. This indicates an access restriction to the record rather than a content update on the study page.
    Difference
    20%
    Check dated 2026-09-20T08:36:14.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.